“Personalized Care With DPP4i SGLT2i Strategy As Initial-Line in the Management of Type 2 Diabetes Mellitus With Cardiovascular Risk: DELPHI Statement”. Cardiology and Cardiovascular Medicine 8, no. 2 (March 28, 2024): 111–117. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/16470.